Cavanaugh Group, Inc.’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.45K Buy
+300
New +$2.15K ﹤0.01% 139

Other funds holding IOVA

Cavanaugh Group, Inc.'s IOVA Position: Q3 2026 in Review

Cavanaugh Group, Inc. opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2026: 300 shares worth $2.45K. The stake represents ﹤0.01% of the portfolio and ranks #139 among its holdings.

334 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Cavanaugh Group, Inc. held 300 shares of Iovance Biotherapeutics worth $2.45K as of Q3 2026.
  • Iovance Biotherapeutics was a new Cavanaugh Group, Inc. position in Q3 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Cavanaugh Group, Inc.'s portfolio in Q3 2026, its #139 holding.
  • 334 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Cavanaugh Group, Inc.'s 13F filing for Q3 2026, filed 17 Nov 2026.